GlassScriptPrepare for your visit
Deann Cobble
Family · Rainsville, AL · NPI 1427475045
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$510.06
in general payments reported to CMS, 2019-2025 · $200 in 2025
The $200 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Novo Nordisk INC $256.84
- Lilly USA, LLC $105.63
- Glaxosmithkline, LLC. $68.39
- Abbott Laboratories $24.29
- Dexcom, INC. $21.24
- Tactile Systems Technology INC $18.93
Drugs and devices associated with these payments
Trelegy Ellipta Wegovy Jardiance Freestyle Libre 3 Dexcom G6 Transmitter Entre Plus Flexitouch Plus Mounjaro Ozempic
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Deann Cobble listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10956846/deann-cobble